# Leadership, Planning and Evaluation

> **NIH CA P30** · WISTAR INSTITUTE · 2026 · $196,034

## Abstract

PROJECT SUMMARY – LEADERSHIP, PLANNING AND EVALUATION
The transformative advances of the Wistar Cancer Center during the last five years would not have been possible
without the combination of stable and experienced Cancer Center leadership and the coordinated activities of
planning and evaluation venues. Relying on the near complete identity between Wistar Institute and Cancer
Center, where 90% of Wistar faculty are Cancer Center members and the Cancer Center Director is also Institute
President and Chief Executive Officer (CEO), planning and evaluation venues leveraged a small but effective
set of advisory committees, incorporated timely input from faculty-driven consultative venues and proactively
engaged all institutional stakeholders in the “ownership” of strategic planning and implementation steps. This
enabled an expansive recruitment campaign that appointed new scientific, administrative and advisory leaders,
a strategic realignment of Cancer Center Programs with the creation of a new Genome Regulation and Cell
Signaling (GRCS) Program, a large, $14.8 million expansion of all eight Cancer Center Support Grant (CCSG)-
supported Shared Resources and best practice Cancer Center governance with judicious and strategic allocation
of pilot project funds for expanded transdisciplinary collaboration. Creating a new paradigm for how a National
Cancer Institute (NCI)-designated “basic” Cancer Center can drive societal impact, planning and evaluation
venues advanced four Wistar discoveries to investigator-initiated, first-in-human oncology clinical trials,
spearheaded a new initiative in population health science and cancer risk jointly with the Helen F. Graham
Community Cancer Center, and pioneered ‘work-study’ programs in collaboration with regional Community
Colleges that redefined workforce development, job creation and public-private partnerships in the life sciences.
Emerging from these advances, the Wistar Cancer Center of 2025 is home to two Specialized Program

## Key facts

- **NIH application ID:** 11333664
- **Project number:** 2P30CA010815-57
- **Recipient organization:** WISTAR INSTITUTE
- **Principal Investigator:** Dario C Altieri
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** CA
- **Fiscal year:** 2026
- **Award amount:** $196,034
- **Award type:** 2
- **Project period:** 1997-04-01T00:00:00 → 2031-02-28T00:00:00

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11333664

## Citation

> US National Institutes of Health, RePORTER application 11333664, Leadership, Planning and Evaluation (2P30CA010815-57). Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/grant/nih/11333664. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
